Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a ...
Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...
The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...
First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
The Hearty Soul on MSN
The world's first reverse aging drug was just injected into a human
The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...
Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.
A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results